A new study published in the Journal of American Medical Association found that patients with exudative age-related macular ...

The use of anticoagulants or antiplatelets was linked to a higher risk of intraocular hemorrhage requiring vitrectomy in ...

An analysis of pivotal phase 3 trials shows supplements to arrest age-related macular degeneration have no effect on ...

Kalaris Therapeutics initiates a phase 1b/2 study for TH103, targeting neovascular age-related macular degeneration and ...

Early in her career, Vaidehi Dedania, MD, encountered a patient with exudative age-related macular degeneration who faced worsening vision and challenges to practicing as a nurse due to the condition.

New research presented today at the European Academy of Dermatology and Venereology (EADV) Congress 2025 reveals that people ...

Recently initiated Phase 1b/2 multiple ascending dose study intended to assess safety and efficacy in nAMD patients receiving four initial ...

A new study explores the "drusen ooze" hypothesis, revealing how drusen can regress without atrophy in age-related macular ...

Future studies are needed to clarify whether antidepressants have a protective role in people at high risk of AMD. Use of ...

Editor’s note: This is a previously posted video, and the below is an automatically generated transcript to be used for informational purposes. Please notify [email protected] if there are concerns ...

The Retina Group of NY offers Vabysmo as a safe, effective and long-lasting treatment for diabetic macular edema and exudative age-related macular degeneration. Vabysmo is an FDA-approved injectable ...